Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Salix Pharmaceuticals Company Profile (NASDAQ:SLXP)

Consensus Ratings for Salix Pharmaceuticals (NASDAQ:SLXP) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.61)
Consensus Price Target: $144.59 7.46% downside)

Current Analysts' Coverage Summary for Salix Pharmaceuticals (NASDAQ:SLXP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/23/2014Cantor FitzgeraldReiterated RatingBuy$154.00 -> $181.00ViewTweet This Rating  Share This Rating on StockTwits
9/19/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $192.00ViewTweet This Rating  Share This Rating on StockTwits
9/12/2014Credit SuisseInitiated CoverageUnderperform$139.00ViewTweet This Rating  Share This Rating on StockTwits
8/20/2014JMP SecuritiesReiterated RatingMarket Outperform$173.00 -> $190.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2014ZacksReiterated RatingOutperform -> Outperform$153.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupDowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$160.00 -> $147.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014MizuhoLower Price TargetBuy$205.00 -> $195.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Deutsche BankInitiated CoverageHold$139.00ViewTweet This Rating  Share This Rating on StockTwits
7/11/2014Sterne AgeeBoost Price TargetBuy$130.00 -> $165.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Leerink SwannReiterated RatingOutperform$162.00 -> $160.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Stifel NicolausBoost Price TargetBuy$150.00 -> $155.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Brean CapitalBoost Price TargetBuy$125.00 -> $150.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014Piper JaffrayReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket Perform$126.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$134.62ViewTweet This Rating  Share This Rating on StockTwits
2/7/2014Roth CapitalBoost Price Target$106.00 -> $110.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Bank of AmericaDowngradeNeutral -> Underperform$86.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Janney Montgomery ScottReiterated RatingBuy$95.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013SusquehannaBoost Price Target$75.00 -> $81.00ViewTweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageNeutral$73.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Buckingham ResearchUpgradeNeutral -> Buy$53.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013RBC CapitalReiterated RatingBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013WallachBeth CapitalBoost Price TargetHold$45.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/1/2012 forward)
Discuss Salix Pharmaceuticals